I
Indivior
Indivior settled a $30 million antitrust lawsuit alleging conspiracy to raise Suboxone prices for indirect purchasers.
ClosedSelected statesClaim status: Closed on February 17, 2024Payout: VariesNo longer claimable
About this settlement
Alleged antitrust conspiracy to inflate prices of Suboxone, an opioid addiction treatment medication.
This settlement resolves claims that Indivior and others conspired to raise the prices of Suboxone and its generic equivalents, affecting indirect purchasers across many U.S. states and territories. Eligible claimants who purchased Suboxone or its AB-rated generics between December 2011 and August 2023 may receive compensation.
Who qualifies
- Individuals or entities who indirectly purchased Suboxone or its AB-rated generic equivalents.
- Purchases made between Dec. 22, 2011 and Aug. 21, 2023.
- Purchases in the listed U.S. states, District of Columbia, and Puerto Rico.
Varies
Claim status: Closed on February 17, 2024